Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy

RTTNews | 740 days ago
Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy

(RTTNews) - Specialty pharmaceutical company Endo International plc (ENDPQ.PK) announced Thursday that its operating company Paladin Labs, Inc. (PLB.TO) has received Health Canada's approval of XCOPRI (cenobamate tablets) for adjunctive therapy in the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy.

Paladin Labs is working collaboratively with the Canadian Agency for Drugs and Technologies in Health (CADTH) and the Institut national d'excellence en santé et en services sociaux (INESSS) to ensure appropriate patients have access to XCOPRI.

Paladin Labs expects to launch XCOPRI in December 2023.

read more
Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates

Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates

Dublin, Ireland -based Endo International plc announced that its operating company Par Pharmaceutical, Inc. is recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The recall, being conducted along with the U.S. Food and Drug Administration, is due to the potential for the presence of silicone particulates in the product solution.
RTTNews | 482 days ago
UK Stocks Turning In Mixed Performance In Cautious Trade

UK Stocks Turning In Mixed Performance In Cautious Trade

U.K. stocks are turning in a mixed performance Tuesday morning as investors are treading cautiously, keeping track of U.S. President Donald Trump's tariff plans and the potential risks to global economic growth.
RTTNews | 8h 4min ago
CAC 40 Slightly Lower In Lackluster Trade

CAC 40 Slightly Lower In Lackluster Trade

French stocks are slightly lower on Tuesday with investors making cautious moves while closely following the developments on the trade front.
RTTNews | 8h 51min ago